Compounds > 4-anisoyl-3-(1,2,2-trimethylcyclopentane carboxylic acid)
Page last updated: 2024-09-05

4-anisoyl-3-(1,2,2-trimethylcyclopentane carboxylic acid) and pazopanib

4-anisoyl-3-(1,2,2-trimethylcyclopentane carboxylic acid) has been researched along with pazopanib in 1 studies

Compound Research Comparison

Studies
(4-anisoyl-3-(1,2,2-trimethylcyclopentane carboxylic acid))		Trials
(4-anisoyl-3-(1,2,2-trimethylcyclopentane carboxylic acid))		Recent Studies (post-2010)
(4-anisoyl-3-(1,2,2-trimethylcyclopentane carboxylic acid))		Studies
(pazopanib)		Trials
(pazopanib)		Recent Studies (post-2010) (pazopanib)
10141,1472371,028

Protein Interaction Comparison

ProteinTaxonomy4-anisoyl-3-(1,2,2-trimethylcyclopentane carboxylic acid) (IC50)pazopanib (IC50)
Multidrug resistance-associated protein 4Homo sapiens (human)8.1
Tyrosine-protein kinase ABL1Homo sapiens (human)2.2043
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)0.21
Cytochrome P450 3A4Homo sapiens (human)0.03
Platelet-derived growth factor receptor betaHomo sapiens (human)0.0837
Cytochrome P450 2D6Homo sapiens (human)0.03
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.0887
Fibroblast growth factor receptor 1Homo sapiens (human)0.1477
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.071
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.032
Fibroblast growth factor receptor 2Homo sapiens (human)0.14
AcetylcholinesteraseHomo sapiens (human)0.93
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.0467
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.4929
Receptor-interacting serine/threonine-protein kinase 1Homo sapiens (human)0.873
Discoidin domain-containing receptor 2Homo sapiens (human)0.0505
Receptor protein-tyrosine kinase Homo sapiens (human)2.2043

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Antonelli, A; Baldini, E; Centanni, M; Elia, G; Fallahi, P; Ferrari, SM; La Motta, C; Mazzi, V; Paparo, SR; Patrizio, A; Piaggi, S; Ragusa, F1

Other Studies

1 other study(ies) available for 4-anisoyl-3-(1,2,2-trimethylcyclopentane carboxylic acid) and pazopanib

ArticleYear
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture.
    International journal of molecular sciences, 2023, Jan-25, Volume: 24, Issue:3

    Topics: Antineoplastic Agents; Humans; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Vascular Endothelial Growth Factor A

2023